Global burden of colorectal cancer in 2022 and projections to 2050: incidence and mortality estimates from GLOBOCAN.
1/5 보강
[BACKGROUND] Colorectal cancer (CRC) is one of the common cancers worldwide and the second leading cause of cancer — related deaths.
APA
Wu S, Zhang Y, et al. (2025). Global burden of colorectal cancer in 2022 and projections to 2050: incidence and mortality estimates from GLOBOCAN.. BMC cancer, 25(1), 1770. https://doi.org/10.1186/s12885-025-15138-0
MLA
Wu S, et al.. "Global burden of colorectal cancer in 2022 and projections to 2050: incidence and mortality estimates from GLOBOCAN.." BMC cancer, vol. 25, no. 1, 2025, pp. 1770.
PMID
41239247 ↗
Abstract 한글 요약
[BACKGROUND] Colorectal cancer (CRC) is one of the common cancers worldwide and the second leading cause of cancer — related deaths. This study aimed to analyze the incidence and mortality of CRC in different global regions through the Global Cancer Observatory (GLOBOCAN) database, so as to provide data support for CRC prevention and treatment.
[METHODS] In this study, data on CRC incidence cases and deaths were extracted from the GLOBOCAN 2022 database for the world, 20 regions, and China, and age—standardized incidence rates (ASIR) and age—standardized mortality rates (ASMR) were analyzed by sex, world region, age, and human development index (HDI). Finally, the incident cases and deaths of CRC from 2022 to 2050 were predicted.
[RESULTS] Data showed that in 2022, there were 1,926,425 global CRC incident cases and 904,019 deaths, with Eastern Asia having the highest numbers. China reported 517,106 incident cases and 240,010 deaths. ASIR and ASMR were higher among males than females across all regions, including China. Globally and in China, the incident cases and deaths of CRC significantly increased after the age of 40. Additionally, regions with a high HDI had higher numbers of incident and death cases of CRC, while those with a low HDI had relatively lower numbers. If CRC incidence rates remained unchanged from 2022, global new CRC cases were projected to reach 2.36 million by 2050, marking a 22.51% increase from 2022; under this same scenario of constant incidence rate, China’s new cases were estimated to decline to 464,000, representing a 10.27% decrease from 2022.
[CONCLUSION] The incidence and mortality of CRC were positively correlated with the HDI level, and gender and age were key factors affecting CRC incidence and mortality. Preventive measures needed to be taken to address the rising trends of global incidence and mortality.
[SUPPLEMENTARY INFORMATION] The online version contains supplementary material available at 10.1186/s12885-025-15138-0.
[METHODS] In this study, data on CRC incidence cases and deaths were extracted from the GLOBOCAN 2022 database for the world, 20 regions, and China, and age—standardized incidence rates (ASIR) and age—standardized mortality rates (ASMR) were analyzed by sex, world region, age, and human development index (HDI). Finally, the incident cases and deaths of CRC from 2022 to 2050 were predicted.
[RESULTS] Data showed that in 2022, there were 1,926,425 global CRC incident cases and 904,019 deaths, with Eastern Asia having the highest numbers. China reported 517,106 incident cases and 240,010 deaths. ASIR and ASMR were higher among males than females across all regions, including China. Globally and in China, the incident cases and deaths of CRC significantly increased after the age of 40. Additionally, regions with a high HDI had higher numbers of incident and death cases of CRC, while those with a low HDI had relatively lower numbers. If CRC incidence rates remained unchanged from 2022, global new CRC cases were projected to reach 2.36 million by 2050, marking a 22.51% increase from 2022; under this same scenario of constant incidence rate, China’s new cases were estimated to decline to 464,000, representing a 10.27% decrease from 2022.
[CONCLUSION] The incidence and mortality of CRC were positively correlated with the HDI level, and gender and age were key factors affecting CRC incidence and mortality. Preventive measures needed to be taken to address the rising trends of global incidence and mortality.
[SUPPLEMENTARY INFORMATION] The online version contains supplementary material available at 10.1186/s12885-025-15138-0.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- Liposuction: Concepts, safety, and techniques in body-contouring surgery.
- Modifications of Z-Epicanthoplasty Combined with Double-Eyelid Blepharoplasty in Asians.
- Multi-omics analysis and experiments validate the tumor-suppressive role of mitochondrial lipid metabolism gene ACSM5 in lung adenocarcinoma and its impact on the immune microenvironment.
- Megakaryocytic Emperipolesis in Acute Myeloid Leukemia with Trisomy 8.
- Machine learning-driven identification of shared and disease-specific mitochondria-related genes in COPD, NSCLC, and NSCLC with COPD.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Opposing prognostic roles of tumor-associated and circulating MMP8 in colorectal cancer.
- Copper-enriched zinc peroxides induced cuproptosis through concurrent metabolic and oxidative dysregulation for boosting immunotherapy in colorectal cancer.
- Editorial: Altered metabolic traits in gastro-intestinal tract cancers, volume II.
- Macrophage deficiency discordantly regulated tumor growth and metastasis through increased thrombospondin-1 production.
- Time-Resolved Oxygen Dynamics Reveals Redox-Selective Apoptosis Induced by Cold Atmospheric Plasma in HT-29 Colorectal Cancer Cells.
- System-Wide Implementation of Colorectal Cancer Screening in a Value-Based Care Setting.